Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

High-dose therapy and autologous stem cell transplantation (HDT/ASCT) is an effective salvage treatment for eligible patients with follicular lymphoma (FL) and early progression of disease (POD). Since the introduction of rituximab, HDT/ASCT is no longer recommended in first remission. We here explo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Alig, Stefan, Jurinovic, Vindi, Shahrokh Esfahani, Mohammad, Haebe, Sarah, Passerini, Verena, Hellmuth, Johannes C., Gaitzsch, Erik, Keay, William, Tahiri, Natyra, Zoellner, Anna, Rosenwald, Andreas, Klapper, Wolfram, Stein, Harald, Feller, Alfred, Ott, German, Staiger, Annette M., Horn, Heike, Hansmann, Martin L., Pott, Christiane, Unterhalt, Michael, Schmidt, Christian, Dreyling, Martin, Alizadeh, Ash A., Hiddemann, Wolfgang, Hoster, Eva, Weigert, Oliver
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2020
Assuntos:
Lymphoid Neoplasia
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509878/
https://ncbi.nlm.nih.gov/pubmed/32941649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002546
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares